The importance of COVID-19 vaccination during lactation DOI Open Access
Maria Isabel Valverde‐Merino, Manuel Gómez‐Guzmán, Celia Piquer‐Martinez

et al.

Infectious Diseases Now, Journal Year: 2023, Volume and Issue: 54(1), P. 104831 - 104831

Published: Nov. 10, 2023

Language: Английский

Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers DOI Creative Commons
Christine Bäuerl, João Zulaica, Luciana Rusu

et al.

iScience, Journal Year: 2023, Volume and Issue: 26(6), P. 106802 - 106802

Published: May 4, 2023

Breastmilk contains antibodies that could protect breastfed infants from infections. In this work, we examined if in breastmilk neutralize SARS-CoV-2 84 samples women were either vaccinated (Comirnaty, mRNA-1273, or ChAdOx1), infected with SARS-CoV-2, both and vaccinated. The neutralization capacity of these sera was tested using pseudotyped vesicular stomatitis virus carrying the Wuhan-Hu-1, Delta, BA.1 Omicron spike proteins. We found natural infection resulted higher neutralizing titers correlated positively levels immunoglobulin A breastmilk. addition, significant differences to produce observed between mRNA-based vaccines adenovirus-vectored ChAdOx1 COVID-19 vaccine. Overall, our results indicate naturally those potentially provide protection infection.

Language: Английский

Citations

4

SARS-CoV-2 neutralizing antibody titers in maternal blood, umbilical cord blood, and breast milk DOI

Mazen Khalifeh,

Lorry G. Rubin,

David Dayya

et al.

Journal of Perinatology, Journal Year: 2023, Volume and Issue: 44(1), P. 28 - 34

Published: Dec. 13, 2023

Language: Английский

Citations

4

COVID-19 booster enhances IgG mediated viral neutralization by human milk in vitro DOI Creative Commons
Vivian Valcarce, Lauren Stewart Stafford, Josef Neu

et al.

Frontiers in Nutrition, Journal Year: 2024, Volume and Issue: 11

Published: Feb. 9, 2024

Background Facilitated by the inability to vaccinate, and an immature immune system, COVID-19 remains a leading cause of death among children. Vaccinated lactating mothers produce specific SARS-CoV-2 antibodies in their milk, capable neutralizing virus vitro . Our objective for this study is assess effect booster dose on antibody concentration viral neutralization plasma, infant stool. Methods Thirty-nine 25 infants were enrolled from December 2020 May 2022. Milk, maternal infants' stool collected at various time-points up 12 months following mRNA vaccination. A subgroup 14 received dose. levels capacities assessed. Results Booster vaccination led significantly higher IgG within human milk breastfed In VSV-gfp-SARS-CoV-2-S-gp, laboratory safe like pseudovirus, improved booster, with 90% increase plasma 60% neutralization. We found that post-booster was highly correlated level. support our correlation result, Protein G column depletion yielded significant reduction ( p = 0.04). Discussion The substantial post-booster, coupled decrease capabilities upon depletion, underscores efficacy doses augmenting response against milk.

Language: Английский

Citations

1

Lactoferrin Supplementation in Preventing and Protecting from SARS-CoV-2 Infection: Is There Any Role in General and Special Populations? An Updated Review of Literature DOI Open Access
Paolo Manzoni, Alessandro Messina, Chiara Germano

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(19), P. 10248 - 10248

Published: Sept. 24, 2024

At the beginning of pandemic, SARS-CoV-2 infection represented a great medical burden worldwide, as targeted and effective therapeutic options were lacking. This resulted in revival existing molecules increasing popularity over-the-counter nutritional supplements. Among latter, lactoferrin has been investigated an adjuvant COVID-19 therapy with conflicting results, mainly depending on different study designs. Considering that is one main components human breast milk anti-microbial anti-inflammatory activity, it conceivable such bioactive molecule could be supporting anti-SARS-CoV-2 therapy, especially infants pregnant women, two subpopulations have poorly evaluated clinical trials. narrative review intended to offer insight into literature lactoferrin’s biological functions protective effects against COVID-19, special focus women their infants.

Language: Английский

Citations

1

Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy DOI Creative Commons
Lin Li, Yusuke Matsui, Mary Prahl

et al.

npj Vaccines, Journal Year: 2024, Volume and Issue: 9(1)

Published: Aug. 27, 2024

Abstract Hybrid immunity against SARS-CoV-2 has not been well studied in pregnancy. We conducted a comprehensive analysis of neutralizing antibodies (nAb) and binding pregnant individuals who received mRNA vaccination, natural infection, or both. A third vaccine dose augmented nAb levels compared to the two-dose regimen infection alone; this effect was more pronounced hybrid immunity. There reduced anti-Omicron nAb, but maternal-fetal transfer efficiency remained comparable that other variants. Vaccine-induced nAbs were transferred efficiently than infection-induced nAbs. Anti-spike receptor domain (RBD) IgG associated with wild-type (Wuhan-Hu-1) following breakthrough infection. Both vaccination anti-RBD IgA, which durable anti-nucleocapsid IgA. IgA response attenuated pregnancy non-pregnant controls. These data provide additional evidence augmentation humoral immune responses

Language: Английский

Citations

0

Non-nutritional use of human milk as a therapeutic agent in neonates: Brain, gut, and immunologic targets DOI
Rebecca Hoban, Krystle Perez, D Taylor Hendrixson

et al.

Early Human Development, Journal Year: 2024, Volume and Issue: 198, P. 106126 - 106126

Published: Sept. 27, 2024

Language: Английский

Citations

0

SARS-CoV-2 Antibody Profiles in Maternal Serum and Breast Milk Following mRNA COVID-19 Vaccination: A Longitudinal Prospective Observational Cohort Study DOI Creative Commons

Hui‐Mien Hsiao,

Langdon S. DiMaggio,

Maria A. Perez

et al.

Vaccines, Journal Year: 2023, Volume and Issue: 11(11), P. 1643 - 1643

Published: Oct. 26, 2023

COVID-19 vaccination during pregnancy protects infants against symptomatic COVID-19. Vaccination of lactating mothers may offer additional protection, but our understanding immune responses in breast milk is limited. We, therefore, performed a single-center prospective cohort study who received mRNA primary vaccine series to evaluate the durability, breadth, and neutralizing capacity antibody milk. Spike IgG- IgA-binding antibodies ancestral SARS-CoV-2 serum were quantified over 9 months using Meso Scale Discovery (MSD) V-PLEX assays, titers compared four variants concern (Alpha, Beta, Delta, Gamma) at single time point. Neutralizing Omicron BA.4/5 before after pseudovirus-neutralization assay. Eleven either Pfizer BNT162b2 (7/11) or Moderna mRNA-1273 (4/11) series. IgG IgA increased following each dose, peaking 1-4 weeks completion. Titers remained significantly elevated for 7-9 months, except which returned baseline within 1 month. Furthermore, binding all included detected collected 1-3 However, while induced strong response more modest milk, it did not induce specimen type. This demonstrates that maternal enhance protection through via IgA-binding-and-neutralizing antibodies; although, variant-specific boosters be required optimize protection.

Language: Английский

Citations

1

The importance of COVID-19 vaccination during lactation DOI Open Access
Maria Isabel Valverde‐Merino, Manuel Gómez‐Guzmán, Celia Piquer‐Martinez

et al.

Infectious Diseases Now, Journal Year: 2023, Volume and Issue: 54(1), P. 104831 - 104831

Published: Nov. 10, 2023

Language: Английский

Citations

0